Details.
Bespoke, independent fundamental research and consulting for the healthcare and technology sectors, with a focus on drug and device companies and emerging technologies such as AI. Coverage includes companies' addressable markets, upcoming catalysts, financials, management teams and business growth strategies. Reports can be customised, include ongoing follow-up and provide independent financial models at the requested level of detail.